TOBAM’s Healthpeak Properties DOC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-3,370
| Closed | -$74K | – | 368 |
|
|
2023
Q1 | $74K | Sell |
3,370
-1,123
| -25% | -$27.8K | ﹤0.01% | 319 |
|
|
2022
Q4 | $113K | Buy |
4,493
+1,183
| +36% | +$28.8K | 0.01% | 273 |
|
|
2022
Q3 | $76K | Hold |
3,310
| – | – | 0.01% | 313 |
|
|
2022
Q2 | $86K | Buy |
3,310
+1,046
| +46% | +$31.7K | 0.01% | 326 |
|
|
2022
Q1 | $78K | Buy |
2,264
+427
| +23% | +$14.4K | ﹤0.01% | 334 |
|
|
2021
Q4 | $66K | Hold |
1,837
| – | – | ﹤0.01% | 316 |
|
|
2021
Q3 | $62K | Hold |
1,837
| – | – | ﹤0.01% | 329 |
|
|
2021
Q2 | $61K | Hold |
1,837
| – | – | ﹤0.01% | 320 |
|
|
2021
Q1 | $58K | Hold |
1,837
| – | – | ﹤0.01% | 315 |
|
|
2020
Q4 | $56K | Hold |
1,837
| – | – | ﹤0.01% | 306 |
|
|
2020
Q3 | $50K | Buy |
+1,837
| New | +$50.3K | ﹤0.01% | 291 |
|
|
2020
Q1 | – | Sell |
-38,566
| Closed | -$1.33M | – | 136 |
|
|
2019
Q4 | $1.33M | Sell |
38,566
-7,797
| -17% | -$273K | 0.08% | 91 |
|
|
2019
Q3 | $1.65M | Sell |
46,363
-20,196
| -30% | -$682K | 0.11% | 86 |
|
|
2019
Q2 | $2.13M | Sell |
66,559
-9,171
| -12% | -$285K | 0.12% | 82 |
|
|
2019
Q1 | $2.37M | Sell |
75,730
-27,679
| -27% | -$843K | 0.12% | 89 |
|
|
2018
Q4 | $2.89M | Buy |
103,409
+8,080
| +8% | +$224K | 0.14% | 94 |
|
|
2018
Q3 | $2.51M | Buy |
95,329
+29,960
| +46% | +$788K | 0.11% | 111 |
|
|
2018
Q2 | $1.69M | Buy |
65,369
+60,267
| +1,181% | +$1.42M | 0.07% | 120 |
|
|
2018
Q1 | $119K | Buy |
+5,102
| New | +$119K | ﹤0.01% | 156 |
|
|
2016
Q1 | – | Sell |
-2,030
| Closed | -$71K | – | 126 |
|
|
2015
Q4 | $71K | Buy |
+2,030
| New | +$67.9K | ﹤0.01% | 108 |
|
|
2015
Q2 | – | Sell |
-1,737,181
| Closed | -$68.4M | – | 135 |
|
|
2015
Q1 | $68.4M | Buy |
1,737,181
+1,575,023
| +971% | +$63.2M | 2.08% | 17 |
|
|
2014
Q4 | $6.5M | Buy |
+162,158
| New | +$6.43M | 0.22% | 74 |
|
Other funds holding DOC
RC
CIM
